Background: Adherens junctions (AJs) provide structure to epithelial tissues by connecting adjacent cells through homophilic E-cadherin interactions and are linked to the actin cytoskeleton via the intermediate binding proteins b-catenin and a-catenin. Rather than being static structures, AJs are extensively remodeled during development, allowing the cell rearrangements required for morphogenesis. Several ''noncore'' AJ components have been identified, which modulate AJs to promote this plasticity but are not absolutely required for cell-cell adhesion. Results: We previously identified dASPP as a positive regulator of dCsk (Drosophila C-terminal Src kinase). Here we show that dRASSF8, the Drosophila RASSF8 homolog, binds to dASPP and that this interaction is required for normal dASPP levels. Our genetic and biochemical data suggest that dRASSF8 acts in concert with dASPP to promote dCsk activity. Both proteins specifically localize to AJs and are mutually required for each other's localization. Furthermore, we observed abnormal E-cadherin localization in mutant pupal retinas, correlating with aberrant cellular arrangements. Loss of dCsk or overexpression of Src elicited similar AJ defects. Conclusions: Because Src is known to regulate AJs in both Drosophila and mammals, we propose that dASPP and dRASSF8 fine tune cell-cell adhesion during development by directing dCsk and Src activity. We show that the dASPPdRASSF8 interaction is conserved in humans, suggesting that mammalian ASPP1/2 and RASSF8, which are candidate tumor-suppressor genes, restrict the activity of the Src protooncogene.
Introduction
Cell-cell contacts are essential for development and adult life of multicellular organisms [1] . The best-characterized form of cellcell contact is the adherens junction (AJ), which links neighboring cells via homotypic E-cadherin (E-Cad) interactions.
The highly conserved intracellular domain of E-Cad binds to b-catenin, which itself binds to a-catenin [2] . Transient interactions between a-catenin and actin filaments link AJs to the cytoskeleton, though the exact nature of this connection remains controversial [3] [4] [5] . AJs are particularly important for the integrity of epithelial tissues. In addition to establishing and maintaining cell-cell adhesion [6] , AJs regulate several aspects of cellular behavior, including cytoskeletal rearrangement and transcription [2] . Inappropriate disruption of cellcell contacts can lead to excess proliferation and is a hallmark of the metastatic process [7, 8] .
Dynamic remodeling of AJs occurs during all major morphogenetic events involving movement and rearrangement of epithelial cells, including convergent extension and gastrulation [9] . AJ remodeling is necessary for the generation of epithelial structures with extremely precise patterns, such as the hexagonal array of ommatidia in the Drosophila compound eye [10] .
SRC signaling is a major cellular pathway known to promote AJ remodeling in development and metastasis. Cellular SRC (c-SRC) is a member of the SRC family kinases (SFKs), which include c-SRC, FYN, and YES. Activated c-SRC is known to regulate AJs by several mechanisms. For example, c-SRC can induce the ubiquitylation of E-Cad by an E3 ubiquitin ligase called Hakai, promoting E-Cad internalization or degradation [11] [12] [13] . In Drosophila, Src42A (one of two c-Src homologs) genetically interacts with E-Cad (encoded by shotgun [shg] in Drosophila), localizes to AJs, and forms a ternary complex with E-Cad and Armadillo (Drosophila b-catenin) [14] . Furthermore, Src42A activation leads to decreased E-Cad protein levels and concurrent stimulation of E-Cad transcription by Armadillo and TCF, which is thought to be important for AJ turnover during morphogenesis [15] .
The C-terminal region of c-SRC and other SFKs is targeted by C-terminal SRC kinase (CSK), which negatively regulates c-SRC by phosphorylating a conserved tyrosine residue (Tyr527 in avian c-SRC) [16] . Drosophila CSK (dCsk) appears to function analogously to mammalian CSK as a negative regulator of SFKs. dCsk is a negative regulator of tissue growth; mutants die as giant pupae and imaginal discs are enlarged as a result of increased proliferation [17] [18] [19] . These observations are seemingly at odds with studies showing that Src activation in Drosophila tissues stimulates proliferation but also leads to considerable apoptosis [20] . A recent report attempted to reconcile this discrepancy, suggesting that lower levels of Src activation induce proliferation and protection from apoptosis, whereas high levels lead to apoptosis and invasive migration [21] .
We previously showed that dCsk activity is modulated by dASPP, the Drosophila homolog of mammalian ASPP1 and ASPP2, which physically interacts with dCsk and enhances its capacity to phosphorylate Src42A [22] . Accordingly, dASPP phenotypes are enhanced by reducing dCsk gene dosage and are rescued by complete removal of Src64B, which functions redundantly with Src42A [14, 23] . Here, we identify dRASSF8 as a new dASPP regulator. dRASSF8 is the homolog of mammalian RASSF7/8 (Ras association domain family 7/8). Ras association (RA) domain-containing proteins are putative Ras effectors; they specifically bind the activated (GTP-bound) form of Ras family GTPases, which function in numerous signal transduction pathways regulating proliferation, apoptosis, and differentiation. Mammalian RASSF family members 1-6 are characterized by their domain structure, with a C-terminal RA domain, a C1-like zinc finger, and a SARAH (Salvador-RASSF-Hippo) domain [24] . Mammalian RASSF7-10 are atypical RASSF proteins because they contain an N-terminal RA domain and lack a C1-like or SARAH domain. Recently, Xenopus RASSF7 was shown to be required for completing mitosis [25] . Human RASSF8 is a putative tumor-suppressor gene; when expressed in lung cancer cells, RASSF8 inhibits anchorage-independent growth [26] . Importantly, the molecular function of RASSF8 has not been elucidated.
Two RASSF family proteins are encoded by the Drosophila genome. dRASSF is similar to human RASSF1-6 and has been linked to the Hippo pathway [27] . dRASSF8 is similar to human RASSF7 and RASSF8, having an N-terminal RA domain. Published genome-wide yeast two-hybrid data suggested that dRASSF8 interacts with dASPP, prompting us to investigate the relationship between these proteins. Based on our genetic and biochemical data, we suggest that the dASPP-dRASSF8 complex regulates AJs by directing the activity of dCsk and Src.
Results
Generation of dRASSF8 Mutants CG5053/dRASSF8 is a conserved gene encoding a 607 amino acid protein with an N-terminal RA domain ( Figure 1A ). dRASSF8 shows significant homology to human RASSF7 and RASSF8 within the RA domain (57% and 70% amino acid identity, respectively).
G15974 (Genexel) is a P element insertion 2 bp upstream of the dRASSF8 transcription start site, which was imprecisely excised to generate deletions at the dRASSF8 locus (Figure 1B) . A precise excision line, dRASSF8
ctrl , was obtained to use as a control and, as expected, had no phenotype. dRASSF8 6 removes the first exon and part of the second exon ( Figure 1B ). An 81 bp section of the 5 0 untranslated region (UTR) of the neighboring gene, tankyrase, is also deleted, raising the possibility that dRASSF8 6 is a double mutant for dRASSF8 and tankyrase. However, the level of tankyrase transcript was not obviously affected in dRASSF8 6 mutants compared to dRASSF8 ctrl flies ( Figure 1D ). Thus, dRASSF8 6 is likely to represent a ''clean'' dRASSF8 allele. When dRASSF8 6 mutant clones were generated in the eyeantennal imaginal discs (the larval precursors to the adult structures), we observed a complete loss of dRASSF8 protein within clones with an antibody directed against dRASSF8 (Figure 1C) . Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that dRASSF8 transcript levels were reduced in all alleles generated. Interestingly, the reduction in transcript observed for each allele corresponded to the strength of phenotype of that allele ( Figure 1D ). dRASSF8 transcript was completely absent from dRASSF8 6 samples, suggesting that it is a null allele ( Figure 1D ).
dRASSF8 Negatively Regulates Tissue Growth dRASSF8 6 homozygotes show a broad wing phenotype. Mutant wings are shorter along the proximodistal axis and broader along the anteroposterior axis compared to dRASSF8 ctrl wings ( Figures 1E-1G ). In density-controlled crosses, the average wing area of dRASSF8 6 homozygous flies was 5.8% larger than dRASSF8 ctrl wings. Importantly, the wing hair density of dRASSF8 6 mutants was comparable to control wings, indicating that dRASSF8 6 mutant wings are larger because they contain more cells rather than larger cells ( Figure 1H ). This suggests that proliferation is increased in dRASSF8 6 mutant wings and that dRASSF8 negatively regulates the size of developing tissues. Accordingly, the adult body weight of dRASSF8 6 mutants is 10.5% higher than that of control flies ( Figure 1H ). The overgrowth phenotype was rescued by ubiquitous expression of dRASSF8 under the control of the armadillo (arm) promoter via the GAL4/UAS system, indicating that the observed phenotypes are specific to loss of dRASSF8 ( Figures  1H and 1I ).
dRASSF8 Is Required for Normal Eye Development dRASSF8 6 homozygous mutants have enlarged, rough eyes compared to controls (Figures 2A and 2B ). High-magnification scanning electron micrographs (SEMs) of dRASSF8 6 eyes reveal severe patterning defects that cause a disruption of the hexagonal ommatidial lattice and clustering of bristles (Figures 2C and 2D ). The phenotype of dRASSF8 6 eyes was examined at the pupal stage with an anti-Arm antibody to mark cell outlines. At 40 hr after puparium formation (APF), patterning is largely complete [28] , dRASSF8 ctrl retinas show a regular arrangement of hexagonal units ( Figure 2E ), the bristle cells are evenly spaced, and each one invariably contacts three secondary pigment cells. At 40 hr APF, dRASSF8 6 mutant retinas show a range of patterning defects ( Figure 2F ; see also Figure S1 available online for further details). Therefore, dRASSF8 is likely to regulate cell-cell adhesion, which plays a crucial role in patterning the Drosophila eye.
A striking phenotype of dRASSF8 6 mutant retinas is the increase in the number of interommatidial cells (IOCs). In 40 hr APF control retinas, the IOCs (secondary and tertiary pigment cells) and bristle cells form a single layer of cells around each ommatidium following cell rearrangements and apoptosis of excess cells ( Figure 2E ). In dRASSF8 6 retinas, we often observed a double layer of IOCs, indicating an excess of this cell type ( Figure 2F ). Quantification (see Supplemental Experimental Procedures) revealed that dRASSF8 6 ommatidia have a significant increase in IOC number (16.21 6 1.88 cells per ommatidium) compared with dRASSF8 ctrl ommatidia (12.16 6 0.49 cells per ommatidium, p < 0.001) ( Figure 2J ). There was no significant difference in the number of bristle cells in dRASSF8 6 ommatidia, but the number was highly variable, presumably because of the altered cell arrangement in mutant retinas ( Figure 2K ).
dRASSF8 Is Required for Apoptosis of Excess Cells in the Drosophila Eye
The increase in the number of IOCs suggests a delay in cellcycle exit and/or a defect in developmental apoptosis, which removes excess IOCs from the retina between 24 hr and 40 hr APF [29] . The dRASSF8 6 eye phenotype is at least partly due to reduced apoptosis, because we observed a notable decrease in active caspase-3 staining in dRASSF8 6 retinas at 27 hr APF (when apoptosis is maximal) ( Figure 2H ) compared to dRASSF8 ctrl retinas ( Figure 2G) . We quantified the level of caspase staining in 27 hr APF retinas containing dRASSF8 6 mutant clones (see Supplemental Experimental Procedures). Quantification revealed that apoptosis was significantly reduced by w20% in dRASSF8 6 mutant tissue compared to control tissue (Figures 2I and 2L; p < 0.001). The reduction in retinal apoptosis was more striking when the entire retina was mutant for dRASSF8, possibly as a result of perdurance of dRASSF8 protein in clones. These data suggest that at least some of the excess IOCs in dRASSF8 6 mutant retinas arise from a failure to undergo apoptosis between 24 and 40 hr APF. We did not observe any obvious change in the levels of apoptosis in dASPP mutant clones at 27 hr APF, suggesting that this phenotype is specific to loss of dRASSF8 ( Figures  S2A and S2B) . dRASSF8/RASSF8 Physically Interacts with dASPP/ASPP1/2 Our initial interest in dRASSF8 stemmed from its interaction with dASPP in published yeast two-hybrid genome-wide data [30] . We confirmed the two-hybrid result by coimmunoprecipitation in Drosophila Kc167 cells cotransfected with Myctagged dASPP and HA-tagged dRASSF8. dASPP-Myc was detected in HA immunoprecipitates, but not in control (GFP) immunoprecipitates ( Figure 3A) . Furthermore, dRASSF8-HA was detected in Myc but not control (GFP) immunoprecipitates ( Figure 3A) , confirming that dRASSF8 and dASPP can indeed associate.
In order to assess whether the dASPP-dRASSF8 association is evolutionarily conserved, we performed an unbiased affinity purification of hRASSF8 complexes from human cells. Epitope-tagged hRASSF8 was tandem affinity purified from stably transfected HEK293 cells. Liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis of the purified complexes revealed that the major interacting partners of hRASSF8 in HEK293 cells are ASPP1 and ASPP2, the human homologs of dASPP ( Figure 3B ; Table S1 ). The MS results were confirmed by coimmunoprecipitation experiments in HEK293 cells. We were able to detect both ASPP1 and ASPP2 in RASSF8 immunoprecipitates, but not in RASSF6 immunoprecipitates ( Figure S3 ). Therefore, ASPP1 and ASPP2 specifically interact with RASSF8. These data strongly suggest that dRASSF8 physically interacts with dASPP, that they function in a common signaling pathway, and that this interaction is conserved in humans.
dRASSF8 Modulates dCsk Activity in a dASPP-Dependent Manner
We have previously demonstrated that dASPP binds to and enhances the kinase activity of dCsk on Src42A in a dosedependent manner [22] . Because dRASSF8 binds to dASPP, we hypothesized that dRASSF8 might modulate dASPP function in the Src pathway, and we used kinase assays to address this possibility. Myc-tagged dCsk was immunoprecipitated from Drosophila Kc167 cells, and in vitro kinase assays were performed with GST-Src42A K267R , a kinase-dead form of Src42A, as a substrate. As expected, the kinase activity of dCsk was potentiated by cotransfection of dASPP ( Figure 3C ). We found that dRASSF8 RNA interference (RNAi) treatment suppressed the enhancement of dCsk kinase activity by dASPP ( Figures 3C and 3D ). By itself, the dRASSF8 RNAi treatment has only a minor effect on dCsk activity. These results suggest that dRASSF8 functions via dASPP to regulate dCsk activity.
We formerly showed that reducing dCsk function in a dASPP 8 mutant background by introducing a strong hypomorphic allele (dCsk j1d8 ) elicits considerable caspase activation in wing discs and a notched wing phenotype [22] . This is also the ). dCsk alone and a negative control (mock immunoprecipitation with GFP antibody, marked by the asterisk) are shown (lanes 1 and 2). Input (1/5) and immunoprecipitated protein levels are shown by western blots. GST-Src42A K276R levels are shown after Coomassie blue staining. dCsk kinase activity was quantified on a phosphorimager and normalized to immunoprecipitated kinase levels (see Experimental Procedures). case when dCsk j1d8 is introduced into a mutant background for dASPP d (Figures 3F and 3H ), an independently generated allele (see Figure S4 for details). In this genetic background, we also observed notching of adult wings (68% of adults had notched wings, n = 100). dRASSF8 and dCsk also genetically interact, though to a weaker extent; removing one copy of dCsk in a dRASSF8 6 background induces moderate levels of ectopic apoptosis in wing discs ( Figures 3E and 3G ) but never results in wing notching (0% of adult wings, n = 150). This finding is consistent with the notion that dRASSF8 influences dCsk activity indirectly via dASPP.
dASPP and dRASSF8 Colocalize at AJs Though our previous study of dASPP [22] suggested that it controls dCsk activity, the spatial aspects of this regulation remain unclear. We therefore generated antibodies for dASPP and dRASSF8, which were used to examine their subcellular localization. In accordance with their physical interaction in cultured cells, we found that dASPP and dRASSF8 colocalize at apical cell membranes in third-instar wing discs ( Figures 4A   and 4B ). To examine this localization more precisely, we looked for colocalization with known apical proteins. Atypical protein kinase C (aPKC) was used as a marker for the subapical domain, E-Cad and Arm were used as markers of AJs, and Discs large (Dlg) was used as a marker of septate junctions [31] . As expected, aPKC is apical to E-Cad (Figure 4C) and Dlg is basal to E-Cad ( Figure 4D ). Interestingly, dRASSF8 colocalizes perfectly with E-Cad ( Figure 4H ) and, accordingly, dASPP colocalizes with Arm ( Figure 4G ). In agreement with this, dASPP is basal to aPKC ( Figure 4E ) and dRASSF8 is apical with respect to Dlg ( Figure 4F ). These results indicate that the dASPP-dRASSF8 complex specifically localizes to AJs in epithelial cells.
dASPP and dRASSF8 Regulate Each Other's Presence at AJs
Because dRASSF8 and dASPP physically interact and colocalize at AJs, we asked whether they regulate each other's localization. We observed a reduction of apical dASPP staining in dRASSF8 6 clones ( Figures 5A and 5B) and milder reduction of apical dRASSF8 staining in dASPP d clones ( Figures 5C and  5D ). These results were confirmed in eye imaginal discs (Figures 5E and 5F).
We addressed whether the effect that dRASSF8 and dASPP have on each other's AJ localization is due to mislocalization and/or a reduction of protein levels. We examined dASPP and dRASSF8 protein levels by western blot in control and mutant wing imaginal disc extracts. dASPP protein levels are strongly reduced in dRASSF8 6 mutants, whereas dRASSF8 levels are only weakly affected in dASPP mutants ( Figure 5G ). Thus, dRASSF8 regulates dASPP protein levels in epithelial cells and hence affects its accumulation at AJs. This is likely to be via a posttranscriptional mechanism because dASPP transcript levels are normal in dRASSF8 mutants ( Figure 1D ). Such mutual stability regulation is not unusual among proteins that are associated in a complex. Because we observed only a minor reduction of dRASSF8 levels in dASPP mutants by western blot, it seems unlikely that this alone can account for the reduction of dRASSF8 observed by immunofluorescence. Therefore, it is possible that dASPP regulates both the localization and levels of dRASSF8 protein. Together, these data suggest that dASPP and dRASSF8 have an interdependent relationship and regulate each other's function in epithelia.
dASPP and dRASSF8 Regulate Cell-Cell Adhesion in the Developing Pupal Retina
We have shown that dASPP and dRASSF8 localize to AJs and are required for correct patterning of the retina, which prompted us to examine whether E-Cad or Arm localization is affected in mutant tissue. We chose to analyze retinas at 26-27 hr APF. At this stage, adhesive forces between different cell types drive the cell rearrangements necessary for establishing the lattice [10] , and dASPP and dRASSF8 localize to AJs (Figures S2C-S2E ). Within dASPP and dRASSF8 mutant clones, E-Cad staining is punctate in appearance and does not form continuous outlines around each cell, as seen in surrounding control tissue (Figures S5A and S5B) . Accordingly, we found that Arm is abnormally localized in dASPP clones ( Figure 6A ). The AJ defects are especially obvious in retinas fully mutant for dASPP or dRASSF8 (Figures 6B-6D) .
The available dASPP-RNAi line strongly diminishes dASPP ( Figure S8D) , and, in 26-27 hr APF retinas, AJ defects were observed in flippase-out (flip-out) clones expressing dASPPRNAi under the control of the actin promoter ( Figure S6A ). We did observe occasional AJ breaks in control tissue at 26-27 hr APF; therefore, we quantified the AJ index (the percentage of the cell membrane positive for E-Cad; see Supplemental Experimental Procedures, Figure S6 , and [32] for details) for control and dASPP-RNAi-expressing cells. The AJ index of control cells was significantly higher (80.4% 6 9.42%, n = 20) than that of dASPP-RNAi cells (45.3% 6 9.38%, n = 20, p < 0.001), confirming that loss of dASPP affects localization of E-Cad in 26-27 hr APF retinas ( Figure 6E ). Interestingly, although obvious patterning defects are observed, the appearance of AJs is normal in dRASSF8 and dASPP mutant retinas at 40 hr APF and does not remain fragmented ( Figure 2F ; Figures 6F and 6G ). This suggests that dRASSF8 and dASPP regulate AJs during the earlier stages of retinal development, when cells undergo dynamic rearrangements, but do not maintain AJs at later stages when patterning is complete.
Because AJs are thought to interact with the actin cytoskeleton, we asked whether apical actin was affected in dASPPdeficient clones. We induced single-cell dASPP-RNAiexpressing flip-out clones early in pupal development, and when two dASPP-RNAi-expressing cells neighbored each other, we commonly found breaks in AJs ( Figure 7A; Figure S7A ), which were associated with gaps in the apical actin network ( Figure 7A ).
Taken together, these results, and the fact that dASPP regulates dCsk activity, raise the possibility that dRASSF8 and dASPP signal through dCsk and Src to regulate AJs during retinal morphogenesis. We noted that the AJ phenotype is more pronounced in dASPP than dRASSF8 clones, which is in agreement with the notion that dASPP is the primary regulator of dCsk in the dASPP-dRASSF8 complex (Figure 3) . Further supporting this model, we found that Arm is extremely poorly localized in 26-27 hr APF retinas expressing dCsk-RNAi ( Figures 7B and 7C) . The AJ defects are more pronounced in dCsk-RNAi retinas than in dASPP mutant retinas, which is consistent with the fact that dCsk has a stronger loss-of-function phenotype than dASPP.
We wished to test whether Src overexpression could recapitulate the effects on AJ protein localization caused by loss of dASPP or dCsk. However, overexpressing either Src42A or Src64B via the GMR-Gal4 driver led to complete eye ablation (data not shown). This is likely the result of massive apoptosis because high levels of Src overexpression cause cell death in Drosophila imaginal discs [20, 23] . Therefore, we generated single-cell flip-out clones, which were analyzed 6-8 hr after induction, with the aim of observing the early consequences of Src overexpression before apoptosis is induced. Expressing UAS-Src42A or UAS-Src64B in these flip-out clones caused severe AJ defects ( Figure 7D and Figure S7B , respectively). The AJ index of control cells (78.7% 6 6.7%, n = 12) was significantly higher than that of Src64B-expressing cells (55.3% 6 9.3%, n = 12, p < 0.001) ( Figure S7C ). It is unlikely that the effect on AJs is simply a consequence of cell death, because we observed Src-overexpressing cells with AJ defects that had clearly not yet begun to delaminate. Together, these results are consistent with a model in which the dASPP-dRASSF8 complex regulates AJs via dCsk and Src. Localization of Dlg, a septate junction protein, is unaffected in dASPP and dRASSF8 mutant tissue ( Figure S5C ; data not shown). This suggests that the dASPPdRASSF8 complex specifically regulates AJs to modulate cell-cell adhesion during retinal morphogenesis, which is consistent with their subcellular localization.
We next asked whether dASPP or dRASSF8 localization is AJ dependent. Expressing a-Catenin-RNAi under the control of the patched (ptc) promoter strongly reduced a-catenin levels ( Figures S8A and S8B) , showing that the RNAi line is extracts were loaded onto SDS polyacrylamide gel electrophoresis (SDS-PAGE) gels and probed against dASPP (top), dRASSF8 (middle), and tubulin (bottom). Molecular weights are indicated on the left in kDa. Note that dASPP protein level is strongly decreased in dRASSF8 6 wing disc extracts, whereas dRASSF8 protein levels are only mildly affected in dASPP mutants.
effective. We also observed a reduction in apically localized dASPP ( Figures 7E and 7F ) and dRASSF8 ( Figure S8C ), suggesting that the localization of dASPP and dRASSF8 is dependent on functional AJs.
Lastly, we explored genetic interactions between the dASPP-dRASSF8 complex and AJs. Removing a copy of shg, which encodes E-Cad, enhanced the dRASSF8 eye phenotype (Figures 7G and 7H) . The eye area of dRASSF8 mutants (100% 6 6.4%, n = 5) was increased by removing a copy of shg (115% 6 3.6%, n = 6, p < 0.01), as was the number of ommatidia per eye (777 6 12, n = 5 compared to 819 6 16, n = 6, p < 0.01). Furthermore, reducing the gene dosage of arm enhanced the dASPP eye phenotype (Figures 7I and 7J) . The eye area of dASPP mutants (100% 6 2.2%, n = 5) was increased by removing a copy of arm (107% 6 3.3%, n = 5, p < 0.01), as was the number of ommatidia (820 6 16, n = 5 compared to 844 6 8, n = 5, p < 0.05). Thus, dRASSF8 and dASPP genetically interact with AJ components, and, together, these data support the notion that the dASPP-dRASSF8 complex regulates AJs during eye development.
Discussion dRASSF8 and N-Terminal RASSF Proteins dRASSF8 is the sole Drosophila homolog of mammalian RASSF7 and RASSF8, which are so-called N-terminal RASSF proteins and the least-studied members of the RASSF family. We have demonstrated that dRASSF8 binds to dASPP in Drosophila cells and that RASSF8 binds to ASPP1 and ASPP2 in human cells ( Figure 3 ; Table S1 ; Figure S3 ), indicating that we have uncovered an evolutionarily conserved relationship between these proteins. The function of RASSF8 is currently unknown, and this study thus provides new insights into the function of N-terminal RASSF proteins.
Future experiments will determine whether RASSF7 also binds ASPP family proteins or whether this function is specific to RASSF8. RASSF7 has been studied in Xenopus and was found to associate with centrosomes and to be required for completing mitosis [25] . In contrast, our data suggest that dRASSF8 is not required for cell-cycle progression because null mutants for dRASSF8 are viable. These findings are suggestive of divergent functions for RASSF7 and RASSF8 in vertebrates, with dRASSF8 being functionally analogous to RASSF8 rather than RASSF7. Indeed, GFP-tagged RASSF7 localizes to the nucleus and centrosomes in Xenopus embryos [25] , whereas we never observed nuclear localization of dRASSF8. Further studies of N-terminal RASSF proteins in vertebrates should clarify whether RASSF7 and RASSF8 have overlapping or independent functions.
The Relationship between dASPP and dRASSF8 Our in vivo data point at a close relationship between dRASSF8 and dASPP, which colocalize and are required for each other's presence at AJs in epithelial cells (Figure 4 ; Figure 5 ). We show that dRASSF8 posttranscriptionally regulates the levels of dASPP protein in epithelia. Thus, it seems likely that binding to dRASSF8 stabilizes dASPP and prevents its degradation, which can be observed for many protein complexes. Overall, our data provide compelling evidence for a functional link between dRASSF8 and dASPP, which is likely to be conserved through to their closest mammalian counterparts, RASSF8 and ASPP1/2.
Our data suggest that dRASSF8 has some dASPP-independent roles. For example, dRASSF8 mutant wings are large and broadened (Figure 1 ), whereas dASPP mutant wings are large but of normal shape [22] . In addition, the dRASSF8 adult eye phenotype is more marked than that of dASPP mutants. Accordingly, we find that dRASSF8, but not dASPP, is required for apoptosis of excess IOCs in the developing pupal retina (Figure 2 ; Figure S2) . It therefore appears that the dRASSF8 eye phenotype results from both reduced apoptosis of IOCs and cell-cell adhesion defects. The subtle differences between the dASPP and dRASSF8 phenotypes indicate unknown functions for dRASSF8, which are not due to its effects on dASPP. Future efforts will be aimed at elucidating these functions.
The dASPP-dRASSF8 Complex Regulates the dCsk-Src Pathway Our data are consistent with a model in which dRASSF8 binds to and positively regulates dASPP and, in this way, promotes dCsk activity indirectly. Our current and previous coimmunoprecipitation experiments support this idea, showing that dRASSF8 and dASPP associate ( Figure 3 ) and that dASPP and dCsk associate [22] . However, we could not detect an interaction between dRASSF8 and dCsk (data not shown), indicating that dRASSF8 does not directly associate with dCsk. The proposed model is also supported by our genetic data; the dRASSF8-dCsk genetic interaction is weaker than the dASPP-dCsk interaction, suggesting that dASPP is the primary regulator of dCsk (Figure 3) . The weaker genetic relationship between dRASSF8 and dCsk can be explained by the observation that some dASPP protein persists in dRASSF8 mutant tissue ( Figure 5 ). These observations suggest that dRASSF8 regulates dCsk via dASPP.
The dASPP-dRASSF8 Complex and Adherens Junctions
Retinal morphogenesis involves dynamic changes in cell-cell contacts to create the final ordered array of photoreceptors and accessory cells [33] . dASPP and dRASSF8 are required for normal E-Cad localization in 26-27 hr APF retinas ( Figure 6 ; Figure S5 ), providing an explanation for the patterning defects in mutant eyes. We propose that the abnormal E-Cad localization in dASPP mutant eyes results from increased Src activity based on several lines of evidence. dASPP binds to and positively regulates dCsk, leading to Src inhibition; therefore, loss of dASPP increases Src activity, which is known to reduce cell-cell adhesion by promoting the internalization and degradation of E-Cad [11] [12] [13] [14] [15] . In agreement with this, we have shown that loss of dCsk or overexpression of either Drosophila Src leads to loss of AJ material in 26-27 hr APF retinas. This claim is further supported by the fact that the dASPP eye phenotype is suppressed by loss of Src64B [22] . Thus, the presence of the dASPP-dRASSF8 complex at AJs may be required to locally prevent inappropriate Src activation and dissolution of AJs.
The fact that dASPP and dRASSF8 mutants are homozygous viable implies that these genes are dispensable for the majority of morphogenetic processes occurring during development. Therefore, the regulation of AJs by dASPP and dRASSF8 may be restricted to the eye. However, as they are expressed in other epithelial tissues, a closer examination of dASPP and dRASSF8 mutants may reveal subtle defects in other morphogenetic processes.
We suggest that dASPP and dRASSF8 are new noncore AJ components and part of the machinery that ensures the fine regulation of AJs by Src during development. This regulation is crucial to provide precisely the right amount of junctional plasticity to allow cell-cell rearrangements and patterning to take place while limiting this plasticity to maintain epithelial coherence and prevent cell delamination. Because the interaction between these proteins is conserved in mammals, this finding is likely to be relevant to mammalian development and to the metastatic process, which is associated with downregulation of E-Cad and loss of cell-cell adhesions [7, 8] . Indeed, ASPP1 knockout mice present defects in the assembly of lymphatic vessels consistent with a potential adhesion defect [34] . This suggests that regulation of cell-cell adhesion may underlie the function of ASPP1/2 and RASSF8 as mammalian tumor suppressors.
Experimental Procedures
For Drosophila genotypes, primer sequences, dRASSF8 and dASPP mutagenesis, RT-PCR, dRASSF8 transgenesis, mass spectrometry, mammalian cell culture, quantification of interommatidial cell number, apoptotic index, and AJ index, see Supplemental Experimental Procedures.
Drosophila Stocks dCsk j1d8 was a gift from R. Cagan. FRT42D, shg R69 , and UAS-Src42A were gifts from P. Rørth. Other stocks were from the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Centre, or have been published previously by our laboratory.
Genetics and Immunohistochemistry
Weight, relative wing size, cell size, and cell number measurements were performed as previously described [22] . Scanning electron microscopy (SEM) was performed as previously described [27] . Pupae were staged by collecting white prepupae and incubating at 25 C for indicated times. The Flippase/Flippase Recombination Target (FLP/FRT) system (eyFLP or hsFLP drivers) was used to generate mosaic tissues. Larval and pupal tissues were immunostained as previously described [22] . Primary antibodies used were rabbit anti-dRASSF8 (see below), rat anti-dASPP38 [22] , rabbit anti-Src64B (see below), rabbit anti-cleaved caspase-3 (Asp175) (Cell Signaling Technology), mouse anti-Discs large (Developmental Studies Hybridoma Bank [DSHB]), and rabbit anti-aPKC (DSHB), all at a concentration of 1/500; rat anti-DE-cadherin (DSHB) and rat anti-a-catenin (DSHB) at 1/50; mouse anti-Armadillo (DSHB) at 1/10; and mouse anti-b-galactosidase (Promega) at 1/1000. Secondary antibodies used were rhodamine red-X donkey anti-rabbit, anti-rat, and anti-mouse, fluorescein isothiocyanate (FITC) donkey anti-rabbit, anti-rat, and antimouse (Jackson ImmunoResearch), goat anti-rat 647, and goat anti-rabbit 633 (Alexa). Phalloidin-594 (Alexa) was incubated with secondary antibodies at 1/100. Fluorescence images were acquired with a Zeiss LSM510 confocal microscope or LEICA SPI TCSNT confocal DMR microscope.
Drosophila Kc167 Cell Assays dRASSF8 was amplified from EST GH01133 (Drosophila Genomics Resource Centre) with primers dRASSF8-5 0 and dRASSF8-3 0 no stop and cloned into the Gateway pActin5C 3xHA vector (Drosophila Gateway Vector Collection). dASPP-RA and dCsk-RB 6xMYC have been previously described [22] . Transfections were done with Effectene reagent (QIAGEN).
Kc167 cells were treated with dRASSF8 or DsRed RNAi for 4 days. RNAi was synthesized with T7 RiboMAX large-scale RNA production systems (Promega). RNAi primers (RNAif dRASSF8, RNAir dRASSF8, RNAif DsRed, and RNAir DsRed) were designed with the GenomeRNAi online tool (http://www.dkfz-heidelberg.de/signaling/ernai/ernai.html).
dRASSF8 transcript analysis was done on total RNA isolated with the RNeasy mini kit (QIAGEN). RNA samples (2 mg per reaction) were treated with RNase-free DNase (Sigma) and were reverse transcribed with cDNA Synthesis System (Roche). The generated cDNA was used for RT-PCR with RNAif dRASSF8, RNAir dRASSF8, RNAif dCsk, RNAir dCsk, and actin 5C primers.
Western Blotting, Immunoprecipitation, Kinase Assays, and Antibody Generation Cells were collected and lysed in 200 ml of lysis buffer. After clearing material by centrifugation, samples were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and proteins transferred to polyvinylidene difluoride (PVDF) membranes.
Immunoprecipitations were done on 250 mg of protein in lysis buffer for 2 hr at 4 C. IP kinase assays were performed as previously described [35] . Ten micrograms of GST Src42A K276R [22] was added to the reactions as a substrate. The Odyssey Infrared Imaging System (LI-COR Biosciences) was used to normalize the amount of immunoprecipitated dCsk-RB by western blot analysis via infrared fluorescence detection. A Molecular Dynamics STORM 860 PhosphorImager was used for autoradiography and quantification of the kinase assays.
Proteins were visualized by immunoblotting with mouse anti-c-Myc (9E10): sc-40, rabbit anti-c-Myc (A-14): sc-789 (Santa Cruz Biotechnology), rat anti-HA (3F10) (Roche), and mouse anti-GFP (Cancer Research UK Monoclonal Antibody Service), all at 1/5000. Anti-tubulin (DSHB) was used for normalization at 1/5000. Chemiluminescence was observed with ECL Plus western blotting detection system (Amersham Biosciences). Rat IRDye 700DX-labeled antibody and rabbit IRDye 800-labeled antibody (Rockland) were used for the Odyssey Infrared Imaging System.
The following antibodies were generated and affinity purified by Eurogentec SA: rabbit anti-dRASSF8 (dRASSF8-08) (against a peptide corresponding to the last 15 C-terminal amino acids), rabbit anti-dASPP (used for western blotting) (against a GST-dASPPCt fusion protein [described in [22] ), and rabbit anti-Src64B (against a peptide corresponding to amino acids 540-552).
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